quinacrine has been researched along with Carcinoma, Epidermoid in 5 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Herein, using in vitro oral squamous cell carcinoma (OSCC) CSCs and in vivo xenograft mice model, we have systematically studied the apoptotic potentiality of quinacrine-gold hybrid nanoparticle (QAuNP) and its underlying mechanism after NIR irradiation." | 1.72 | NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells. ( Chatterjee, S; Das, B; Dash, SR; Kundu, CN; Panda, R; Paul, S; Pradhan, R; Sethy, C; Sinha, S; Tripathy, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dash, SR | 1 |
| Chatterjee, S | 1 |
| Sinha, S | 1 |
| Das, B | 1 |
| Paul, S | 1 |
| Pradhan, R | 1 |
| Sethy, C | 1 |
| Panda, R | 1 |
| Tripathy, J | 1 |
| Kundu, CN | 1 |
| Friedman, J | 1 |
| Nottingham, L | 1 |
| Duggal, P | 1 |
| Pernas, FG | 1 |
| Yan, B | 1 |
| Yang, XP | 1 |
| Chen, Z | 1 |
| Van Waes, C | 1 |
| Bauer, F | 2 |
| Callaway, JL | 1 |
5 other studies available for quinacrine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Gold; Humans; | 2022 |
Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cy | 2007 |
Quinacrine hydrochloride drug eruption (tropical lichenoid dermatitis). Its early and late sequelae and its malignant potential: a review.
Topics: Atrophy; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Drug Eruptions; Humans; Lichen P | 1981 |
Late sequelae of atabrine dermatitis--a new pre-malignant entity.
Topics: Carcinoma, Squamous Cell; Drug Eruptions; Humans; Precancerous Conditions; Quinacrine; Skin Neoplasm | 1978 |
Late sequelae of quinacrine dermatitis, a new premalignant entity.
Topics: Carcinoma, Squamous Cell; Hand; Humans; Lichen Planus; Male; Quinacrine; Skin Neoplasms | 1979 |